questionsmedicales.fr
Sciences sociales
Sociologie
Facteurs sociologiques
Culture (sociologie)
Culture (sociologie) : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture (sociologie) : Questions médicales les plus fréquentes",
"headline": "Culture (sociologie) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture (sociologie) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture (sociologie)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs sociologiques",
"url": "https://questionsmedicales.fr/mesh/D066252",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs sociologiques",
"code": {
"@type": "MedicalCode",
"code": "D066252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acculturation",
"alternateName": "Acculturation",
"url": "https://questionsmedicales.fr/mesh/D000069",
"about": {
"@type": "MedicalCondition",
"name": "Acculturation",
"code": {
"@type": "MedicalCode",
"code": "D000069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.079"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Comparaison interculturelle",
"alternateName": "Cross-Cultural Comparison",
"url": "https://questionsmedicales.fr/mesh/D003431",
"about": {
"@type": "MedicalCondition",
"name": "Comparaison interculturelle",
"code": {
"@type": "MedicalCode",
"code": "D003431",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.257"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Caractéristiques culturelles",
"alternateName": "Cultural Characteristics",
"url": "https://questionsmedicales.fr/mesh/D003466",
"about": {
"@type": "MedicalCondition",
"name": "Caractéristiques culturelles",
"code": {
"@type": "MedicalCode",
"code": "D003466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.329"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Compétence culturelle",
"alternateName": "Cultural Competency",
"url": "https://questionsmedicales.fr/mesh/D054521",
"about": {
"@type": "MedicalCondition",
"name": "Compétence culturelle",
"code": {
"@type": "MedicalCode",
"code": "D054521",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.364"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diversité culturelle",
"alternateName": "Cultural Diversity",
"url": "https://questionsmedicales.fr/mesh/D018864",
"about": {
"@type": "MedicalCondition",
"name": "Diversité culturelle",
"code": {
"@type": "MedicalCode",
"code": "D018864",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.450"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diversité, équité, inclusion",
"alternateName": "Diversity, Equity, Inclusion",
"url": "https://questionsmedicales.fr/mesh/D000092783",
"about": {
"@type": "MedicalCondition",
"name": "Diversité, équité, inclusion",
"code": {
"@type": "MedicalCode",
"code": "D000092783",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.450.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Culture populaire",
"alternateName": "Popular Culture",
"url": "https://questionsmedicales.fr/mesh/D000076207",
"about": {
"@type": "MedicalCondition",
"name": "Culture populaire",
"code": {
"@type": "MedicalCode",
"code": "D000076207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.628"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture (sociologie)",
"alternateName": "Culture",
"code": {
"@type": "MedicalCode",
"code": "D003469",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrew Whiten",
"url": "https://questionsmedicales.fr/author/Andrew%20Whiten",
"affiliation": {
"@type": "Organization",
"name": "Centre for Social Learning and Cognitive Evolution, School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK. Electronic address: a.whiten@st-andrews.ac.uk."
}
},
{
"@type": "Person",
"name": "Cecilia Heyes",
"url": "https://questionsmedicales.fr/author/Cecilia%20Heyes",
"affiliation": {
"@type": "Organization",
"name": "All Souls College and Department of Experimental Psychology, University of Oxford, Oxford OX1 4AL, UK."
}
},
{
"@type": "Person",
"name": "Jung Yul Kwon",
"url": "https://questionsmedicales.fr/author/Jung%20Yul%20Kwon",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: jungyulkwon@asu.edu."
}
},
{
"@type": "Person",
"name": "Alexandra S Wormley",
"url": "https://questionsmedicales.fr/author/Alexandra%20S%20Wormley",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: awormley@asu.edu."
}
},
{
"@type": "Person",
"name": "Michael E W Varnum",
"url": "https://questionsmedicales.fr/author/Michael%20E%20W%20Varnum",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: mvarnum@asu.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The actual status of drug prices and adjustment factors for drug price calculation: an analysis of ultra-orphan drug development in Japan.",
"datePublished": "2022-11-08",
"url": "https://questionsmedicales.fr/article/36348359",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13023-022-02526-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "COSMO models for the pharmaceutical development of parenteral drug formulations.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37120066",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.04.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Overcoming Pharmaceutical Bottlenecks for Nucleic Acid Drug Development.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36624086",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.accounts.2c00464"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical trial considerations for pediatric cancer drug development.",
"datePublished": "2023-02-07",
"url": "https://questionsmedicales.fr/article/36749066",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10543406.2023.2172424"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing incentives to ACCELERATE drug development for paediatric cancer.",
"datePublished": "2023-01-16",
"url": "https://questionsmedicales.fr/article/36645217",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.5627"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences sociales",
"item": "https://questionsmedicales.fr/mesh/D012942"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sociologie",
"item": "https://questionsmedicales.fr/mesh/D012961"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs sociologiques",
"item": "https://questionsmedicales.fr/mesh/D066252"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture (sociologie)",
"item": "https://questionsmedicales.fr/mesh/D003469"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture (sociologie) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture (sociologie)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture (sociologie)",
"description": "Comment évaluer une culture dans un groupe social ?\nQuels outils mesurent la culture d'une organisation ?\nQuelles méthodes étudient les changements culturels ?\nComment identifier les sous-cultures ?\nQuels indicateurs montrent une culture forte ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture (sociologie)",
"description": "Quels signes montrent un choc culturel ?\nComment reconnaître une culture toxique ?\nQuels effets le stress culturel a-t-il ?\nQuels comportements révèlent une culture inclusive ?\nQuels symptômes d'une culture d'entreprise faible ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture (sociologie)",
"description": "Comment prévenir le choc culturel ?\nQuelles pratiques favorisent une culture inclusive ?\nComment éviter une culture d'entreprise toxique ?\nQuelles actions pour renforcer la cohésion culturelle ?\nComment sensibiliser à la diversité culturelle ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture (sociologie)",
"description": "Comment améliorer une culture d'entreprise ?\nQuelles stratégies pour gérer le choc culturel ?\nComment promouvoir une culture positive ?\nQuels outils pour évaluer la culture d'une organisation ?\nComment intégrer la diversité dans la culture ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture (sociologie)",
"description": "Quelles conséquences d'une culture d'entreprise faible ?\nQuels risques d'un choc culturel prolongé ?\nComment une culture toxique affecte-t-elle la santé ?\nQuelles répercussions d'une mauvaise gestion culturelle ?\nQuels effets d'une culture non inclusive ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture (sociologie)",
"description": "Quels facteurs augmentent le choc culturel ?\nQuels éléments favorisent une culture toxique ?\nQuels risques liés à une culture d'entreprise homogène ?\nQuels facteurs influencent la diversité culturelle ?\nQuels éléments déclenchent des conflits culturels ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer une culture dans un groupe social ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'observation des comportements, des rituels et des valeurs partagées."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent la culture d'une organisation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes, des interviews et des analyses de documents internes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles méthodes étudient les changements culturels ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse historique, les études de cas et les enquêtes longitudinales sont courantes."
}
},
{
"@type": "Question",
"name": "Comment identifier les sous-cultures ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des différences de valeurs et de comportements au sein d'un groupe aide."
}
},
{
"@type": "Question",
"name": "Quels indicateurs montrent une culture forte ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un engagement élevé, des valeurs partagées et une communication ouverte sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels signes montrent un choc culturel ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Désorientation, frustration, et sentiment d'aliénation sont des symptômes fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une culture toxique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un manque de communication, des conflits fréquents et un faible moral des employés sont des signes."
}
},
{
"@type": "Question",
"name": "Quels effets le stress culturel a-t-il ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner de l'anxiété, de la dépression et des problèmes de santé physique."
}
},
{
"@type": "Question",
"name": "Quels comportements révèlent une culture inclusive ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La diversité, l'égalité des chances et la valorisation des différences sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une culture d'entreprise faible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un turnover élevé, une faible productivité et un manque d'innovation sont des symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir le choc culturel ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Offrir des formations interculturelles avant un déplacement aide à prévenir le choc culturel."
}
},
{
"@type": "Question",
"name": "Quelles pratiques favorisent une culture inclusive ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de diversité, des formations et des événements culturels renforcent l'inclusion."
}
},
{
"@type": "Question",
"name": "Comment éviter une culture d'entreprise toxique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager la communication ouverte et traiter rapidement les conflits aide à prévenir la toxicité."
}
},
{
"@type": "Question",
"name": "Quelles actions pour renforcer la cohésion culturelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des activités de groupe et des discussions sur les valeurs partagées renforce la cohésion."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à la diversité culturelle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ateliers, des séminaires et des ressources éducatives sensibilisent à la diversité."
}
},
{
"@type": "Question",
"name": "Comment améliorer une culture d'entreprise ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations, des ateliers de team-building et une communication ouverte sont efficaces."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour gérer le choc culturel ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes d'orientation et de mentorat aident à atténuer le choc culturel."
}
},
{
"@type": "Question",
"name": "Comment promouvoir une culture positive ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager la reconnaissance, la collaboration et le feedback constructif favorise une culture positive."
}
},
{
"@type": "Question",
"name": "Quels outils pour évaluer la culture d'une organisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes de satisfaction et des audits culturels sont des outils utiles."
}
},
{
"@type": "Question",
"name": "Comment intégrer la diversité dans la culture ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des politiques inclusives et des formations sur la diversité est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles conséquences d'une culture d'entreprise faible ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture faible peut entraîner un turnover élevé, une faible productivité et des conflits."
}
},
{
"@type": "Question",
"name": "Quels risques d'un choc culturel prolongé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un choc culturel prolongé peut mener à des problèmes de santé mentale et à l'isolement social."
}
},
{
"@type": "Question",
"name": "Comment une culture toxique affecte-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer du stress, de l'anxiété et des problèmes de santé physique chez les employés."
}
},
{
"@type": "Question",
"name": "Quelles répercussions d'une mauvaise gestion culturelle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion peut entraîner des conflits internes, une baisse de moral et une perte de talents."
}
},
{
"@type": "Question",
"name": "Quels effets d'une culture non inclusive ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut créer des sentiments d'exclusion, de discrimination et nuire à la performance globale."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le choc culturel ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de préparation, le manque de soutien social et des différences culturelles importantes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels éléments favorisent une culture toxique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un leadership autoritaire, une communication déficiente et des valeurs contradictoires favorisent la toxicité."
}
},
{
"@type": "Question",
"name": "Quels risques liés à une culture d'entreprise homogène ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture homogène peut mener à l'innovation limitée et à l'exclusion de talents divers."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la diversité culturelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les politiques d'embauche, la sensibilisation et l'éducation influencent la diversité culturelle."
}
},
{
"@type": "Question",
"name": "Quels éléments déclenchent des conflits culturels ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des différences de valeurs, de croyances et de pratiques peuvent déclencher des conflits culturels."
}
}
]
}
]
}
Extremely high prices facilitate drug development for ultra-rare diseases (ultra-orphan drugs). However, various problems arise in terms of healthcare financing and fairness, and the status of ultra-o...
Drug prices tended to increase as the expected number of patients to whom the drug was administered decreased; however, this trend diminished when the expected number of patients was less than 1000. O...
The status of drug prices and expected sales differed beyond a threshold of 1000 expected patients, indicating that recovering the development cost for ultra-orphan drugs is difficult. In addition, th...
The aqueous solubility of active pharmaceutical ingredients is one of the most important features to be considered during the development of parenteral formulations in the pharmaceutical industry. Com...
The outbreak of the coronavirus disease 2019 (COVID-19) pandemic and swift approval of two mRNA vaccines have put nucleic acid therapeutics in the spotlight of both the scientific community and the ge...
Oncology has been one of the most active therapeutic areas in medicinal products development. Despite this fact, few drugs have been approved for use in pediatric cancer patients when compared to the ...
More effective incentives are needed to motivate paediatric oncology drug development, uncoupling it from dependency on adult drug development. Although the current European and North-American legisla...
We propose changes in the timing and nature of the rewards within the European Paediatric Medicine Regulation (PMR) and Regulation on Orphan Medicinal Products (both currently under review), which wou...
We suggest modifying the PMR to ensure mechanism-of-action driven mandatory PIP and reorganization of incentives to a stepwise and incremental approach. Interim and final deliverables should be define...
Additionally, to address the critical gap in the current framework where there is a complete lack of incentives to promote paediatric-specific cancer drug development, we propose the introduction of e...
G-protein-coupled receptors (GPCRs) can form homodimers or heterodimers that modulate specific signal transduction pathways to regulate a wide range of physiological and pathological functions. As suc...
Diabetic retinopathy is one of the withering disorders that has been making the lives of patients miserable. Arising as a result of chronic high blood sugar levels in diabetes patients, retinopathy ha...
While the drug development literature provides numerous estimates of the financial costs to bring a new drug to market, the investment of patient-participants in the research process has not been desc...
Five drugs are now approved or in trials for genetic condition that triggers misplaced bone growth....
Osteoarthritis (OA) is the most common form of arthritis worldwide, affecting ~500 million people, yet there are no effective treatments to halt its progression. Without any structure-modifying agents...